Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Oxaceprol Sustained Release Tablets 600 mg
Therapeutic Category
Anti-Inflammatories, Orthopedics, Rheumatology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*1*10
Price
₹551/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Oxaplor OD Tablet contains Oxaceprol, a medicine used to help reduce inflammation and pain in joints. It works by lowering the activity of certain substances in the body that cause swelling and discomfort. Doctors often prescribe it for conditions like osteoarthritis and other joint disorders to improve movement and relieve pain. Being a sustained-release tablet, it releases the medicine slowly over time, providing long-lasting effect with fewer doses.
Generally well tolerated. Some people may experience mild stomach upset, nausea, diarrhea, or headache. Rarely, allergic reactions or skin rashes can occur.
Management of osteoarthritis Relief of joint pain, stiffness, and swelling in degenerative joint conditions
Take Oxaplor OD Tablet exactly as prescribed by your doctor. Do not exceed the recommended dose. It is best taken after meals to avoid stomach upset. Inform your doctor if you are pregnant, breastfeeding, have kidney or liver problems, or any history of stomach ulcers before use.
Store in a cool, dry place below 30°C, away from sunlight and moisture. Keep out of reach of children.
Composition : Oxaceprol (200mg) Capsule
Composition : Diacerein (50mg) + Glucosamine Sulfate Potassium Chloride (750mg) + Methyl Sulfonyl Methane (250mg)
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Diacerein 50mg Capsule
Composition : Myo Inositol 2000mg + Pyridoxal 5 Phosphate 2.4mg + Calcium 1000mg + Vitamin D3 (600IU)
Composition : Calcitriol 0.25mcg + Calcium Citrate Maleate 500mg + Vitamin K27 50mg +Zinc 7.5 mg (DRUG)
Composition : Cissus Quadrangularis Extract - 500mg Moringa Oleifera - 100mg Softgel
Composition : Bromelain (90mg) + Trypsin (48mg) + Rutoside (100mg)
Composition : Bromelain (180mg) + Trypsin (96mg) + Rutoside (200mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Oxaceprol Sustained Release 600mg Tablet has growing demand in the orthopedics, rheumatology, pain management, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on musculoskeletal and chronic pain care portfolios.
Medical distributors and agencies can benefit from consistent demand for joint health and osteoarthritis management under medical supervision. Oxaceprol Sustained Release 600mg is an anti-inflammatory agent that helps reduce inflammation, pain, and joint stiffness associated with degenerative joint disorders Commonly prescribed for the symptomatic management of osteoarthritis, inflammatory joint disorders, and other musculoskeletal conditions, as advised by healthcare professionals Helps improve joint mobility, physical function, and overall quality of life by reducing inflammation and discomfort during long-term treatment The sustained-release (SR) formulation provides prolonged drug release, supporting once-daily dosing, improved patient compliance, and sustained therapeutic effect Should be used under medical supervision and as part of a comprehensive treatment plan that may include physiotherapy, weight management, and regular exercise where appropriate. Patients should be monitored for therapeutic response and tolerability during prolonged therapy Frequently utilized in orthopedic clinics, rheumatology practices, pain management centers, sports medicine clinics, and hospitals Widely prescribed by orthopedic surgeons, rheumatologists, pain specialists, and general physicians for chronic joint disorders This strengthens a comprehensive orthopedics and pain management portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Oxaceprol Sustained Release 600mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from consistent prescription demand, growing orthopedic and rheumatology market opportunities, long-term therapy requirements, reliable supply chain support, repeat business, and attractive margins in the musculoskeletal healthcare segment.
Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality orthopedic and pain management products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.